Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes

Inflammation

Volumn 34, Issue 6, 2011, Pages 659-667

  Lou, Tianjiong ^a   Zhang, Zhongai ^a   Xi, Zhilei ^a   Liu, Kang ^b   Li, Lin ^b   Liu, Baolin ^b   Huang, Fang ^b  

^a Anorectal Center of Nanjing Hospital of Traditional Chinese Medicine   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

berberine; hepatocytes; inflammation; insulin resistance

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BERBERINE; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; PALMITIC ACID; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SALICYLATE SODIUM; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; GLYCOGEN ANALYSIS; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BERBERINE; CELL LINE; HEPATOCYTES; HUMANS; INFLAMMATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INTERLEUKIN-6; PALMITATES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82955235212     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9276-2     Document Type: Article

References (44)

1. AH Mokdad ES Ford BA Bowman WH Dietz F Vinicor VS Bales JS Marks 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 Journal of the American Medical Association 289 76 79 12503980 10.1001/jama.289.1.76 (Pubitemid 36026281)
2. GS Hotamisligil NS Shargill BM Spiegelman 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Science 259 87 91 7678183 10.1126/science.7678183 1:CAS:528:DyaK3sXnvFaitw%3D%3D (Pubitemid 23036092)
3. R Feinstein H Kanety MZ Papa B Lunenfeld A Karasik 1993 Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates Journal of Biological Chemistry 268 26055 26058 8253716 1:CAS:528:DyaK3sXmsVOksbw%3D
4. GS Hotamisligil 2003 Inflammatory pathways and insulin action International Journal of Obesity and related Metabolic Disorders 27 Suppl 3 S53 S55 14704746 10.1038/sj.ijo.0802502 1:CAS:528:DC%2BD2cXls1Ki (Pubitemid 38019190)
5. DE Moller 2000 Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes Trends in Endocrinology and Metabolism 11 212 217 10878750 10.1016/S1043-2760(00)00272-1 1:CAS:528:DC%2BD3cXks12rtbo%3D (Pubitemid 30603166)
6. M Yuan N Konstantopoulos J Lee L Hansen ZW Li M Karin SE Shoelson 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ Science 293 1673 1677 11533494 10.1126/science.1061620 1:CAS:528:DC%2BD3MXms1Chtrw%3D (Pubitemid 32807849)
7. RS Hundal KF Petersen AB Mayerson PS Randhawa S Inzucchi SE Shoelson GI Shulman 2002 Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes Journal of Clinical Investigation 109 1321 1326 12021247 1:CAS:528:DC%2BD38XjvFCls74%3D (Pubitemid 34546896)
8. J Kuhlmann C Neumann-Haefelin U Belz J Kalisch HP Juretschke M Stein E Kleinschmidt W Kramer AW Herling 2003 Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1 H-spectroscopic study in Zucker diabetic fatty rats Diabetes 52 138 144 12502504 10.2337/diabetes.52.1.138 1:CAS:528:DC%2BD3sXisVaitQ%3D%3D (Pubitemid 36042118)
9. A Dresner D Laurent M Marcucci ME Griffin S Dufour GW Cline LA Slezak DK Andersen RS Hundal DL Rothman KF Petersen GI Shulman 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity Journal of Clinical Investigation 103 253 259 9916137 10.1172/JCI5001 1:CAS:528:DyaK1MXltFequw%3D%3D (Pubitemid 29053143)
10. D Cai M Yuan DF Frantz PA Melendez L Hansen J Lee SE Shoelson 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nature Medicine 11 2 183 190 15685173 10.1038/nm1166 1:CAS:528:DC%2BD2MXpvF2ntQ%3D%3D (Pubitemid 40321354)
11. A Seppälä-Lindroos S Vehkavaara AM Häkkinen T Goto J Westerbacka A Sovijärvi J Halavaara H Yki-Järvinen 2002 Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men Journal of Clinical Endocrinology and Metabolism 87 3023 3028 12107194 10.1210/jc.87.7.3023 (Pubitemid 34816338)
12. L Ryysy AM Häkkinen T Goto S Vehkavaara J Westerbacka J Halavaara H Yki-Järvinen 2000 Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients Diabetes 49 749 758 10905483 10.2337/diabetes.49.5.749 1:CAS:528:DC%2BD3cXjsF2ms74%3D (Pubitemid 30339990)
13. CW Lau XQ Yao ZY Chen WH Ko Y Huang 2001 Cardiovascular actions of berberine Cardiovascular Drug Reviews 19 234 244 11607041 10.1111/j.1527-3466. 2001.tb00068.x 1:CAS:528:DC%2BD38XktFKntQ%3D%3D (Pubitemid 34019907)
14. Y Zhang X Li D Zou W Liu J Yang N Zhu L Huo M Wang J Hong P Wu G Ren G Ning 2008 Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine Journal of Clinical Endocrinology and Metablism 93 2559 2565 10.1210/jc.2007-2404 1:CAS:528:DC%2BD1cXoslykurw%3D (Pubitemid 352008520)
15. YS Lee WS Kim KH Kim MJ Yoon HJ Cho Y Shen JM Ye CH Lee WK Oh CT Kim C Hohnen-Behrens A Gosby EW Kraegen DE James JB Kim 2006 Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states Diabetes 55 2256 2264 16873688 10.2337/db06-0006 1:CAS:528:DC%2BD28Xot1Ogur4%3D (Pubitemid 44743622)
16. J Yin R Hu M Chen J Tang F Li Y Yang J Chen 2002 Effects of berberine on glucose metabolism in vitro Metabolism 51 1439 1443 12404195 10.1053/meta.2002.34715 1:CAS:528:DC%2BD38XosF2jtL0%3D
17. SH Leng FE Lu LJ Xu 2004 Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion Acta Pharmacological Sinica 25 496 502 1:CAS:528:DC%2BD2cXjtFKgsbg%3D
18. BS Ko SB Choi SK Park JS Jang YE Kim S Park 2005 Insulin sensitizing and insulinotropic action of berberine from Coptidis Rhizoma Biological and Pharmaceutical Bulletin 28 1431 1437 16079488 10.1248/bpb.28.1431 1:CAS:528:DC%2BD2MXhtVWrsr3K (Pubitemid 41379694)
19. HW Jeong KC Hsu JW Lee M Ham JY Huh HJ Shin WS Kim JB Kim 2009 Berberine suppresses proinflammatory responses through AMPK activation in macrophages American Journal of Physiology-Endocrinology and Metabolism 296 955 964 10.1152/ajpendo.90599.2008
20. BH Choi IS Ahn YH Kim JW Park SY Lee CK Hyun MS Do 2006 Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte Experimental and Molecular Medicine 38 599 605 17202835 1:CAS:528:DC%2BD2sXmvV2isw%3D%3D
21. SE Baldeweg A Golay A Natali B Balkau S Del Prato SW Coppack 2000 Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR) European Journal of Clinical Investigation 30 45 52 10620001 10.1046/j.1365-2362.2000.00597.x 1:CAS:528:DC%2BD3cXptVamsg%3D%3D (Pubitemid 30071856)
22. M Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 248 254 942051 10.1016/0003-2697(76)90527-3 1:CAS:528:DyaE28XksVehtrY%3D
23. J Bolinder DA Kerckhoffs E Moberg E Hagstrom-Toft P Arner 2000 Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects Diabetes 49 797 802 10905489 10.2337/diabetes.49.5.797 1:CAS:528:DC%2BD3cXjsF2ms7g%3D (Pubitemid 30339996)
24. G Boden 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 46 3 10 8971073 10.2337/diabetes.46.1.3 1:CAS:528:DyaK2sXks1aj (Pubitemid 27009941)
25. DE Kelley LJ Mandarino 2000 Fuel selection in human skeletal muscle in insulin resistance: a reexamination Diabetes 49 677 683 10905472 10.2337/diabetes.49.5.677 1:CAS:528:DC%2BD3cXjsF2nu7c%3D (Pubitemid 30339979)
26. GF Lewis A Carpentier K Adeli A Giacca 2002 Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocrine Reviews 23 201 229 11943743 10.1210/er.23.2.201 1:CAS:528: DC%2BD38XjsFWjtrw%3D (Pubitemid 34299024)
27. DE Kelley TM McKolanis RA Hegazi LH Kuller SC Kalhan 2003 Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance American Journal of Physiology 285 906 916
28. H Shi MV Kokoeva K Inouye I Tzameli H Yin JS Flier 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance Journal of Clinical Investigation 116 3015 3025 17053832 10.1172/JCI28898 1:CAS:528: DC%2BD28XhtFyrsLfE (Pubitemid 44684486)
29. HW Jeong KC Hsu JW Lee M Ham JY Huh HJ Shin WS Kim JB Kim 2009 Berberine suppresses pro-inflammatory responses through AMPK activation in macrophages American Journal of Physiology-Endocrinology and Metabolism 296 E955 E964 19208854 10.1152/ajpendo.90599.2008 1:CAS:528:DC%2BD1MXkvVyhtbc%3D
30. JJ Senn PJ Klover IA Nowak A Robert 2002 Mooney Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes Diabetes 51 3391 3399 12453891 10.2337/diabetes.51.12.3391 1:CAS:528:DC%2BD38Xptl2ntbk%3D (Pubitemid 35403441)
31. GS Hotamisligil P Peraldi A Budavari R Ellis MF White BM Spiegelman 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance Science 1996 271 665 668 10.1126/science.271.5249.665 (Pubitemid 26052915)
32. KT Uysal SM Wiesbrock MW Marino GS Hotamisligil 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 610 614 9335502 10.1038/39335 1:CAS:528:DyaK2sXmslWgu7k%3D (Pubitemid 27446179)
33. GS Hotamisligil A Budavari D Murray BM Spiegelman 1994 Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes central role of tumor necrosis factor-α Journal of Clinical Investigation 94 1543 1549 7523453 10.1172/JCI117495 1:CAS:528:DyaK2cXmt1OrtL8%3D
34. AT Cheung D Ree JK Kolls J Fuselier DH Coy M Bryer-Ash 1998 An in vivo model for elucidation of the mechanism of tumor necrosis factor-(TNF-α)- induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-α Endocrinology 139 4928 4935 9832430 10.1210/en.139.12.4928 1:CAS:528:DyaK1cXns1ehtrc%3D (Pubitemid 28533439)
35. AT Cheung J Wang D Ree JK Kolls M Bryer-Ash 2000 Tumor necrosis factor-induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase Diabetes 49 810 819 10905491 10.2337/diabetes.49.5.810 1:CAS:528:DC%2BD3cXjsF2ms7Y%3D (Pubitemid 30339998)
36. Y Yamada EM Webber I Kirillova JJ Peschon N Fausto 1998 Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor Hepatology 28 959 970 9755232 10.1002/hep.510280410 1:CAS:528:DyaK1cXmvVSlurk%3D (Pubitemid 28450256)
37. JS Campbell L Prichard F Schaper J Schmitz A Stephenson-Famy ME Rosenfeld GM Argast PC Heinrich N Fausto 2001 Expression of suppressors of cytokine signaling during liver regeneration Journal of Clinical Investigation 107 1285 1292 11375418 10.1172/JCI11867 1:CAS:528:DC%2BD3MXjsl2ntrY%3D (Pubitemid 32494545)
38. JJ Senn PJ Klover IA Nowak RA Mooney 2002 Interleukin-6 induces cellular insulin resistance in hepatocytes Diabetes 12 3391 3399 10.2337/diabetes.51.12. 3391 (Pubitemid 35403441)
39. YF Liu A Herschkovitz HS Boura D Ronen K Paz D Leroith Y Zick 2004 Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance Molecular and Cellular Biology 24 9668 9681 15485932 10.1128/MCB.24.21.9668-9681.2004 1:CAS:528:DC%2BD2MXltl2gsg%3D%3D (Pubitemid 39391701)
40. YF Liu K Paz A Herschkovitz A Alt T Tennenbaum SR Sampson M Ohba T Kuroki D LeRoith Y Zick 2001 Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins Journal of Biological Chemistry 276 14459 14465 11278339 1:CAS:528:DC%2BD3MXjt12rtLY%3D
41. E Park V Wong X Guan AI Oprescu A Giacca 2007 Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo Journal of Endocrinology 2 323 331 10.1677/JOE-07-0005 (Pubitemid 350143112)
42. Shi, Shu, Liu Xiaomei, Song Lina, Zhou Jinfang, Song Jumin. 2009. Effect of berberine on the gene expression of IRS-1/-2, p85 in 2-type diabetic rats. Zhejiang Journal of Traditional Chinese Medicine 44: 254-257.
43. A Toker AC Newton 2000 Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site Journal of Biological Chemistry 12 8271 8274 10.1074/jbc.275.12.8271 (Pubitemid 30180163)
44. SH Kim EJ Shin ED Kim T Bayaraa SC Frost CK Hyun 2007 Berberine activates GLUT1-mediated glucose uptake in 3 T3-L1 adipocytes Biological & Pharmaceutical Bulletin 30 2120 2105 10.1248/bpb.30.2120 1:CAS:528: DC%2BD1cXisVCltQ%3D%3D (Pubitemid 350097053)